Loading...
Roundtable: How I treat a newly diagnosed patient with high-risk myeloma
Initial management of high-risk myeloma remains a treatment challenge. Risk is defined by a combination of clinical and biological features, with fluorescence in situ hybridization detection of specific cytogenetic abnormalities driving categorization. High-risk abnormalities include t(4;14), t(14;1...
Na minha lista:
| Udgivet i: | Hematology Am Soc Hematol Educ Program |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Hematology
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6913472/ https://ncbi.nlm.nih.gov/pubmed/31808841 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/hematology.2019000015 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|